XRP trades in one-month highs as institutional interest is growing but nears a technical resistance zone.
With institutional interest growing, particularly tied to XRP’s use cases in cross-border payments, regulatory clarity, and speculation around possible ETF-like products, the XRP price keeps rising.
The token’s price action is also feeding the bullish case with noticeable “whale” accumulation, with large holders stepping in, which strengthened support around key levels in August and September.
XRP's rise through its July-to-September downtrend line at $3.0100 is bullish with the 24 August high at $3.1263 representing the next technical upside target, together with the 16 August high at $3.1576.
Were these levels to be exceeded, the late July-to-August highs at $3.3306-to-$3.3826 would likely be next in focus.
Were XRP to be rejected by its $3.1263-to- $3.1576 resistance area and slip through its September accelerated uptrend line at $3.0000 and its 9 September low at $2.9344, the early September high at $2.8864 would probably be back in the frame.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.